Thursday, 06 September 2012 13:54

Benefits of short daily home hemodialysis in the FREEDOM Study: is it about person, place, time, or treatment?

By  Khaled Abdel-Kader and Mark L Unruh
Rate this item
(0 votes)

Many end-stage renal disease patients receive thrice-weekly hemodialysis (HD) and report impairments in health-related quality of life (HRQOL). Recent studies indicate that short daily HD may improve HRQOL. High-quality studies exploring the burdens and costs to patients, caregivers, and society are necessary before widespread adoption can be advocated. Further research exploring the mechanisms by which these benefits are realized is also important, as many patients are likely to opt out of short daily HD.

Click here below to read the article:

Kidney Int 82: 511-513; doi:10.1038/ki.2012.161

Additional Info

  • Language: English
  • Contains Audio: No
  • Content Type: Articles
  • Source: KI
  • Year: 2012
  • Members Only: No
Read 3848 times Last modified on Tuesday, 17 January 2017 06:19

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact


Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact